Advances in the Management of Medullary Thyroid Carcinoma: Focus on Peptide Receptor Radionuclide Therapy

Effective treatment options in advanced/progressive/metastatic medullary thyroid carcinoma (MTC) are currently limited. As in other neuroendocrine neoplasms (NENs), peptide receptor radionuclide therapy (PRRT) has been used as a therapeutic option in MTC. To date, however, there are no published rev...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Med
Main Authors: Grossrubatscher, Erika, Fanciulli, Giuseppe, Pes, Luca, Sesti, Franz, Dolci, Carlotta, de Cicco, Federica, Colao, Annamaria, Faggiano, Antongiulio
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7693147/
https://ncbi.nlm.nih.gov/pubmed/33138305
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9113507
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados